Complement component 3 deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280133OMIM:613779D84.1
Who is this for?
Show terms as
17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Complement component 3 (C3) deficiency is a rare primary immunodeficiency disorder caused by a complete or near-complete absence of complement component 3, a central protein in the complement system. C3 plays a pivotal role in all three complement activation pathways (classical, alternative, and lectin) and is essential for opsonization of pathogens, immune complex clearance, and inflammatory responses. The condition is also known as C3 deficiency or selective complement C3 deficiency. It is caused by pathogenic variants in the C3 gene located on chromosome 19p13.3. Patients with C3 deficiency typically present in early childhood with recurrent, severe bacterial infections, particularly caused by encapsulated organisms such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Common infections include pneumonia, meningitis, and sepsis. A significant proportion of affected individuals also develop immune complex-mediated glomerulonephritis, specifically membranoproliferative glomerulonephritis, which can progress to renal failure. This renal involvement results from impaired clearance of immune complexes due to the absence of functional C3. Some patients may also develop autoimmune manifestations, including features resembling systemic lupus erythematosus. There is no specific curative treatment for C3 deficiency. Management focuses on prompt and aggressive treatment of infections with appropriate antibiotics, prophylactic antibiotic therapy in some cases, and vaccination against encapsulated organisms, although vaccine efficacy may be reduced due to the complement deficiency. Fresh frozen plasma infusions have been used in some patients to temporarily restore C3 levels, but this approach carries risks including allergic reactions and is not a long-term solution. Renal disease is managed with standard nephrology care, and some patients may ultimately require renal transplantation. Genetic counseling is recommended for affected families.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Complement component 3 deficiency.

View clinical trials →

No actively recruiting trials found for Complement component 3 deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Complement component 3 deficiency community →

Specialists

17 foundView all specialists →
DH
Dae Youn Hwang
NEW HAVEN, CT
Specialist
2 Complement component 3 deficiency publications
SP
So Hae Park
Specialist
1 Complement component 3 deficiency publication
YR
Ye Eun Ryu
NEW YORK, NY
Specialist
1 Complement component 3 deficiency publication
HS
Hee Jin Song
Specialist
2 Complement component 3 deficiency publications
JK
Ji Eun Kim
Specialist
2 Complement component 3 deficiency publications
AS
Ayun Seol
Specialist
2 Complement component 3 deficiency publications
EP
Eun Seo Park
Specialist
2 Complement component 3 deficiency publications
YR
Yu Jeong Roh
KATY, TX
Specialist
1 Complement component 3 deficiency publication
TK
Tae Ryeol Kim
Specialist
1 Complement component 3 deficiency publication
KP
Ki Ho Park
Specialist
1 Complement component 3 deficiency publication
JH
Jin Tae Hong
Specialist
1 Complement component 3 deficiency publication
SC
Sun Il Choi
Specialist
1 Complement component 3 deficiency publication
SL
Su Jeong Lim
Specialist
1 Complement component 3 deficiency publication
SW
Su Ha Wang
Specialist
1 Complement component 3 deficiency publication
YK
Ye Ryeong Kim
Specialist
1 Complement component 3 deficiency publication
JP
Jignesh Patel, M.D., Ph.D.
Specialist
PI on 1 active trial
YM
Yulong He, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Complement component 3 deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Complement component 3 deficiencyForum →

No community posts yet. Be the first to share your experience with Complement component 3 deficiency.

Start the conversation →

Latest news about Complement component 3 deficiency

1 articles
NewsRSSApr 22, 2026
Test Your Knowledge About the Etiology of TK2d
This article invites people to take a quiz about TK2d, a rare genetic disease, to test their understanding of what causes it. After completing the quiz, you can
See all news about Complement component 3 deficiency

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Complement component 3 deficiency

What is Complement component 3 deficiency?

Complement component 3 (C3) deficiency is a rare primary immunodeficiency disorder caused by a complete or near-complete absence of complement component 3, a central protein in the complement system. C3 plays a pivotal role in all three complement activation pathways (classical, alternative, and lectin) and is essential for opsonization of pathogens, immune complex clearance, and inflammatory responses. The condition is also known as C3 deficiency or selective complement C3 deficiency. It is caused by pathogenic variants in the C3 gene located on chromosome 19p13.3. Patients with C3 deficienc

How is Complement component 3 deficiency inherited?

Complement component 3 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Complement component 3 deficiency typically begin?

Typical onset of Complement component 3 deficiency is childhood. Age of onset can vary across affected individuals.

Which specialists treat Complement component 3 deficiency?

17 specialists and care centers treating Complement component 3 deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.